Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-25T01:33:50.324Z Has data issue: false hasContentIssue false
  • English
  • Français

The new Amplatzer duct occluder II: when is its use advantageous?

Published online by Cambridge University Press:  23 March 2011

Zuzana Venczelova ,
Peter Tittel  and
Jozef Masura
Zuzana Venczelova*
Affiliation:
Department of Functional Diagnostics, Children's Cardiac Centre, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
Peter Tittel
Affiliation:
Department of Functional Diagnostics, Children's Cardiac Centre, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
Jozef Masura
Affiliation:
Department of Functional Diagnostics, Children's Cardiac Centre, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
*
Correspondence to: Zuzana Venczelova, Department of Functional Diagnostics, National Institute of Cardiovascular Diseases – Children's Cardiac Centre, Limbova 1, 833 51 Bratislava, Slovakia. Tel: 004212 59371864; Fax: 004212 54792317; E-mail: suzanne@venczel.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

To determine the safety and efficacy of the Amplatzer duct occluder and the Amplatzer duct occluder II in different types of arterial ducts, and to determine in which types of ducts the use of this new device can be advantageous.

Methods

All children with a device-based ductal closure between September, 2005 and February, 2010 were included. We retrospectively analysed the catheterisation and follow-up data.

Results

Between September, 2005 and February, 2010, 44 ducts were closed with the Amplatzer duct occluder – group Amplatzer duct occluder – and 52 ducts were closed with the Amplatzer duct occluder II – group Amplatzer duct occluder II. In the Amplatzer duct occluder group, the mean age was 3 years and 4 months, and the mean weight was 14.7 kilograms. Closure was successfully performed in all children. Complete closure at 24 hours was attained in 42 of 44 children (95.45%). No major complications occurred. In the Amplatzer duct occluder II group, the mean age was 6 years and 2 months, and the mean weight was 25.4 kilograms. Closure was successfully performed in all children, except in two children in whom the occluder protruded into the aortic isthmus and was replaced by the Amplatzer duct occluder. Complete closure at 24 hours was attained in 51 of 52 children (98.08%). No major complications occurred.

Conclusion

In our experience, duct closure with the Amplatzer duct occluder II is a safe and effective method. The advantages of using it are the smaller sheath sizes and softer shape.

Keywords

Deviceinterventional cardiologyKrichenko typefollow-up
Type
Original Articles
Information
Cardiology in the Young , Volume 21 , Issue 5 , 09 September 2011 , pp. 495 - 504
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Mitchell, SC, Korones, SB, Berendes, HW. Congenital heart disease in 56,109 births: incidence and natural history. Circulation 1971; 43: 323–332.CrossRefGoogle Scholar
2.Keane, JF, Fyler, DC. Patent ductus arteriosus. In: Keane FJ (ed.). Nadas’ Pediatric Cardiology. Elsevier, Philadelphia, 2006, 617–624.CrossRefGoogle Scholar
3.Wang, JK, Wu, MH, Hwang, JJ, Chiang, FT, Lin, MT, Lue, HC. Transcatheter closure of moderate to large patent ductus arteriosus with the Amplatzer duct occluder. Catheter Cardiovasc Interv 2007; 69: 572–578.CrossRefGoogle ScholarPubMed
4.Masura, J, Tittel, P, Gavora, P, Podnar, T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 2006; 151: 755.e7–755.e10.CrossRefGoogle ScholarPubMed
5.Thanopoulos, BD, Hakim, FA, Hiari, A, et al. Further experience with transcatheter closure of the patent ductus arteriosus using the Amplatzer duct oocluder. J Am Coll Cardiol 2000; 35: 1016–1021.CrossRefGoogle Scholar
6.Ewert, P. Challenges encountered during closure of patent ductus arteriosus. Pediatr Cardiol 2005; 26: 224–229.CrossRefGoogle ScholarPubMed
7.Abadir, S, Boudjemline, Y, Rey, C, et al. Significant persistent ductus arteriosus in infants less or equal to 6kg: percutaneous closure or surgery? Arch Cardiovasc Dis 2009; 102: 533–540.CrossRefGoogle ScholarPubMed
8.Giroud, JM, Jacobs, JP. Evolution of strategies for management of the patent arterial duct. Cardiol Young 2007; 17 (Suppl 2): 68–74.CrossRefGoogle ScholarPubMed
9. AGA Medical Corporation. International products – PDA devices, from the web site of the AGA Medical Corporation, 2008.Google Scholar
10.Krichenko, A, Benson, L, Burrows, P, Möes, CA, McLaughlin, P, Freedom, RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877–879.CrossRefGoogle ScholarPubMed
11.Dua, J, Chessa, M, Piazza, L, et al. Initial experience with the new Amplatzer duct occluder II. J Invasive Cardiol 2009; 21: 401–405.Google ScholarPubMed
12.Bhole, P, Miller, V, Mehta, C, Stumper, O, Reinhardt, Z, De Giovanni, JV. Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion. Catheter Cardiovasc Interv 2009; 74: 762–769.CrossRefGoogle ScholarPubMed
13.Forsey, J, Kenny, D, Morgan, G, et al. Early clinical experience with the new Amplatzer ductal occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv 2009; 74: 615–623.CrossRefGoogle ScholarPubMed
14.Thanopoulos, B, Eleftherakis, N, Tzannos, K, Stefanadis, C. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 2008; 156: 917.e1–917.e6.CrossRefGoogle ScholarPubMed
15.Thanopoulos, BV, Eleftherakis, N, Tzannos, K, Stefanadis, C, Giannopoulos, A. Further experience with catheter closure of patent ductus arteriosus using the new Amplatzer duct occluder in children. Am J Cardiol 2010; 105: 1005–1009.CrossRefGoogle ScholarPubMed
16.Saliba, Z, El-Rassi, I, Abi-Warde, MT, et al. The Amplatzer duct occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol 2009; 22: 496–502.CrossRefGoogle Scholar
17.Vanuranakis, M, Tzannos, KA, Thanopoulos, BD, Vlasis, K, Stefanadis, C. Severe hemolysis complicating trancatheter occlusion of a patent ductus arteriosus: the importance of elimination of residual flow. Hellenic J Cardiol 2007; 48: 373–376.Google Scholar